Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
The processing of covalent aflatoxin B1 (AFB1)-DNA adducts was investigated in confluent normal fibroblasts (NF) and xeroderma pigmentosum skin fibroblasts of Complementation Group A (XPA) following treatment with rat liver microsome-activated AFB1 for 30 min. Following rapid DNA isolation at slightly acidic pH by a new filter technique, more than 90% of the adducts corresponded to 2,3-dihydro-2-(N7-guanyl)-3-hydroxy-AFB1 (AFB1-N7-Gua) according to the analysis of acid hydrolysates by high-pressure liquid chromatography. The changes in adduct concentration and composition were compared between DNA isolated immediately following AFB1 treatment and incubated at neutrality in vitro and DNA in situ in the cell isolated after different lengths of incubation. The following conclusions were reached from the observed differences in the kinetics of adduct removal from free DNA and DNA in situ in NF and XPA: (a) AFB1-N7-Gua is removed spontaneously and enzymatically in NF but probably only spontaneously in XPA. This result suggests that these lesions are removed via nucleotide excision repair in NF; (b) the putative 2,3-dihydro-2(N5-formyl-2',5',6'-triamino-4'-oxo-N5-pyrimidyl)-3-hydroxyaflatoxin B1 is formed in a secondary reaction from AFB1-N7-Gua in vitro and in situ in the cell. It accumulates more rapidly and to a greater extent in XPA than in NF and persists in both cells types over prolonged periods. The reaction of AFB1-N7-Gua to 2,3-dihydro-2-(N5-formyl-2',5'6'-triamino-4'-oxo-N5-pyrimidyl)-3-hydroxyaflatox in B1 represents the transformation of a repairable lesion to a nonrepairable, persistent lesion.
D016604:Aflatoxin B1; D000348:Aflatoxins / Q000378:metabolism*; D001711:Biotransformation; D002478:Cells, Cultured; D004247:DNA / Q000378:metabolism*; D004260:DNA Repair; D006801:Humans; D007700:Kinetics; D008862:Microsomes, Liver / Q000378:metabolism
D000348:Aflatoxins; D004247:DNA; D016604:Aflatoxin B1